Navigation Links
BioGenex and Abbott Molecular Conclude Successful Partnership
Date:3/4/2013

FREMONT, Calif., March 4, 2013 /PRNewswire/ -- After a long and successful collaboration and partnership, BioGenex and Abbott Molecular have announced that BioGenex will take over direct sales and support responsibility for co-branded Xmatrx instruments, auto FISH reagents and consumables, with immediate effect.

Xmatrx FISH, the product of successful partnership, enabled walk-away automation of all assay steps required to perform Abbott's FISH tests from baking to final cover slip, providing ready-to-view slides.

BioGenex will support current Xmatrx customers, and if desired by the customers, will enable their Xmatrx system to perform other slide based assays e.g. IHC, ISH, SS, and miRNA in addition to FISH.

"Abbott and BioGenex are working closely and are committed to ensure seamless transition. Hospitals, labs, and research institutions that use Xmatrx can be assured that they will get best in class service and support. BioGenex and Abbott representatives have jointly advised the customers of this change. "The transition to the next phase of our relationship is a testament to the truly unique capabilities of the Xmatrx platform, which allows automation of molecular pathology staining assays, from microtome to microscope," said Dr. Krishan Kalra , CEO, BioGenex.

About Xmatrx® ELITE
Xmatrx® ELITE is an integrated system consisting of a platform technology for full automation for any slide based assay e.g. IHC, ISH, SS, miRNA & FISH. This truly All-in-One fully automated system from microtome to microscope maximizes the testing capacity, minimizes hands-on time, and ensures consistent and quality results every time.

Xmatrx® ELITE enabled with specially formulated and optimized reagents, including primary antibodies, nucleic acid probes, special stains, detection kits and consumables delivers optimum performance yet is cost effective for total automation. This underlies our commitment to provide flexible work flow solutions for today, tomorrow and beyond.

About us [www.biogenex.com]
BioGenex designs, develops, and commercializes advanced fully-automated Molecular Diagnostic Systems for cancer diagnosis, prognosis, therapy selection, personalized medicine, and life science research. Our products include fully automated instruments, Nucleic Acid probes, Antibodies, detection systems, ancillary reagents, and consumables to provide the total solution for ISH, CISH, IHC, SS, FISH, and in Situ PCR. Our customer focused approach, with premier after-sales support and excellent technical service, provides the best-in-class customer care. Our spirit of innovation drives us to deliver cutting edge technology, years ahead of our competition, and the finest reagents and instruments for life Science research and diagnostics.

Visit BioGenex @ USCAP 2013 | Booth No. 130 | Mar.04-Mon to Mar.06-Wed, 2013 | Baltimore Convention Center | USA

Media Contact:

Saba Ammari, 5108241400, s.ammari@biogenex.com

USA Office: T: +1-510-824-1400 | F: +1-510-824-1490 | Toll Free: 1-[800] 421-4149 | 49026 Milmont Drive Fremont CA 94538 | U.S.A.

India Office : T: +91-40-27185500 | F: +91-40-27185511/21 | 225 Cherlapally - Industrial Development Area - Phase II Hyderabad, AP | India 500051


'/>"/>
SOURCE BioGenex
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Abaxis Announces Exclusive Distribution Agreement with Abbott
2. Abbott Sued for False Claims Related to its Blockbuster Drug TriCor
3. Actinium Pharmaceuticals Inc. Pays Regulatory Milestone to Abbott Biotherapeutics Corp.
4. Abbott, The Abbott Fund And Direct Relief International Reach Key HIV Testing Milestones: 20 Million Tests Provided Over 10 Years, And More Than 150,000 HIV Cases Prevented In Children
5. Abbott Presents Results of Clinical Studies Evaluating Its Investigational Treatment for Advanced Parkinsons Disease
6. Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
7. Abbott Announces Collaboration with Syngene to Open First Nutrition R&D Center in India
8. BiOptix announces expansion of Innovators Program at Molecular Med TRI-CON 2013
9. Global Market for Molecular Diagnostics to Exceed $10.7 Billion by 2018, Regenerative Medicine to Top $4.4 Billion
10. Trovagene to Introduce First Urine-Based Molecular Diagnostic Test for Transrenal Cancer Mutation Monitoring
11. DioGenix and Fast Forward Collaborate to Develop Blood-Based Molecular Diagnostic for Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
(Date:6/23/2016)... -- , , , WHEN: , ... , , , LOCATION: , , , Online, with free ... EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice President ... Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... is witnessing an exceptional era. Several new demand spaces, such as ...
(Date:6/23/2016)... 23, 2016 Revolutionary technology includes ... Oticon , industry leaders in advanced audiology and hearing ... Oticon Opn ™, the world,s first internet connected hearing ... IoT devices.      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ... number of ,world firsts,: , TwinLink™ - ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
Breaking Medicine News(10 mins):